HEADLINE People's Daily Tonight: Podcast News (2/23/2018 Fri.)

HEADLINE

People's Daily Tonight: Podcast News (2/23/2018 Fri.)

People's Daily app

21:26, February 23, 2018

221554360ajw.jpg

This is People's Daily Tonight, your news source from China. 

______

2,980 deputies elected to China's top legislature

大会堂.jpg

A total of 2,980 deputies to the 13th National People's Congress (NPC), China's top legislature, have been elected and are awaiting final confirmation.

A report on the qualifications of the new NPC deputies, elected from 35 electoral units across the country, was submitted to the NPC Standing Committee for confirmation.

______

India carries out most trade remedy investigations against China

zqd12agu1h3.jpg

India has carried out eight trade remedy investigations against China in January and February, according to statistics from China's Ministry of Commerce.

As of August 2017, India has launched 212 anti-dumping investigations against China.

China has been urging India to legitimately using trade remedy measures, noting that the abuse of such measures would cast a negative influence on the two nations' trade and economic ties.

______

World's first autologous lung stem cell transplant conducted in China

手术.png

Researchers from the Shanghai-based Tongji University successfully regenerated human lung through stem cell transplantation. The process and results of the research were published in the science journal Protein & Cell on Jan. 17.

Transplantation is believed to be an effective solution for patients with severe lung diseases, but its application is largely limited due to the extreme lack of donor lungs, as well as the severe side effects resulting from immune-rejection.

The success of the clinical trial offers a new option for transplantation therapy.

______

China to revise oath of allegiance for officials

231837448222.jpg

China plans to revise the oath of allegiance to the Constitution taken by people in public office to include adjectives of "great" and "modern" before "a socialist country."

The draft revision was submitted to a session of the Standing Committee of the NPC for review on Friday.

______

Australian PM: China is no threat to us; it has no 'hostile intent'

23134159bejm.jpg

China is not a threat to Australia because it has no "hostile intent," Australian Prime Minister Malcom Turnbull told the media on Thursday as he starts his three-day visit to the United States.

According to The Guardian's report, the leader tried to play down a more hostile approach to China by the US, rejecting the idea that the two superpower countries are in competition.

______

Two Koreas to talk about DPRK's participation in Paralympics

Cgqg11ZoQ2qACsusAAAu7F71wrw075.jpg

South Korea and the DPRK will hold talks on Feb. 27 to discuss the DPRK's participation in the Winter Paralympic Games.

South Korea offered Tuesday to hold the working-level talks, and the DPRK accepted the proposal earlier in the day.

______

Political settlement is the only way out for Syria: Chinese envoy

23132334zrl7.jpg

A Chinese envoy said a political settlement is the only way out for the ongoing crisis in Syria and called for resuming dialogues and negotiations among relevant parties. 

One of the Chinese permanent representative to the United Nations, expressed concern over the escalated security situation in parts of Syria, including its capital Damascus and the Eastern Ghouta.

China would like to express its profound sympathy to the Syrian people for their suffering, and condemns all acts of violence that target civilians and civilian facilities.

______

And that's People's Daily Tonight. Thanks for joining us.

(Produced by Chen Zilin, Wang Yi and Liang Peiyu)

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue